SCHEMBL20733788

SCHEMBL20733788

c1ccc(-c2nc(-c3ncc4ccccc4n3)nc(-c3nnc4c5cccnc5c5ncccc5c4n3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 6/20 0.43
▸ NPC1 O15118 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ PDE5A O76074 6/20 0.40
▸ CYP3A4 P08684 3/20 0.39
▸ CYP2D6 P10635 3/20 0.39
▸ CYP2C9 P11712 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ CLK4 Q9HAZ1 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ GLA P06280 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ ATM Q13315 1/20 0.37
▸ CYP2C19 P33261 2/20 0.36
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20733793 0.91 CYP1A2 (0.50) CYP1A2NPC1MAPTLMNARECQL
SCHEMBL20733787 0.84 CYP1A2 (0.42) CYP1A2NPC1MAPTLMNARECQL
SCHEMBL20733786 0.84 CYP1A2 (0.47) CYP1A2NPC1MAPTLMNARECQL
SCHEMBL12761842 0.80 NPC1 (0.45) NPC1MAPTLMNARECQLRAB9A
SCHEMBL20733794 0.79 CYP1A2 (0.47) CYP1A2NPC1MAPTLMNARECQL
SCHEMBL20733798 0.79 ABCG2 (0.36) NPC1MAPTRAB9APDE5AMEN1
SCHEMBL20733785 0.78 CYP1A2 (0.41) CYP1A2NPC1MAPTLMNARECQL
SCHEMBL20733796 0.77 L3MBTL1 (0.48) NPC1MAPTLMNASMN1; SMN2CYP3A4
SCHEMBL24184680 0.73 CYP1A2 (0.65) CYP1A2NPC1MAPTLMNARECQL
Quinoline SCHEMBL28071900 0.72 ALDH1A1 (0.59) CYP1A2NPC1MAPTLMNARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2023-02-23 — — US disclosed
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OXER1 CYP1A2 869/4885NPC1 1206/4885MAPT 1710/4885
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OXER1 CYP1A2 869/4885NPC1 1206/4885MAPT 1710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback